Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital PCR Platform Harnesses Microfluidic Technology for Quantification of Genetic Targets

By LabMedica International staff writers
Posted on 03 Apr 2023

Digital PCR (dPCR) is a powerful method that enables the precise and ultra-sensitive measurement of nucleic acids. More...

This technique offers enhanced accuracy and sensitivity for detecting low-level abundance nucleic acids in the case of bacterial and viral pathogens, resulting in absolute quantification and remarkable specificity. Although qPCR has been the go-to technique for pathogen detection, dPCR provides superior accuracy in the presence of inhibitors and does not require a standard curve for absolute quantification. Now, an easy-to-use dPCR platform harnesses cutting-edge microfluidic technology to integrate the dPCR workflow onto a single consumable chip, resulting in higher sensitivity and accuracy when detecting low-level abundance nucleic acids in the detection of bacterial and viral pathogens.

The naica system from Stilla Technologies (Villejuif, France) harnesses the key principles of digital PCR and is designed to provide a sensitive, fast, and easy-to-use platform for the quantification of genetic targets. It boasts the highest multiplexing capacity currently offered in the market for the simultaneous detection and quantification of multiple genetic targets in a single run. The naica system is based on Stilla’s Crystal Digital PCR technology that partitions samples into a large array of thousands of individual droplet crystals – each its own reaction compartment – before amplifying nucleic acid molecules in each droplet crystal. These reactions are tagged with fluorophores to be read using up to six different fluorescence light channels. This results in a fast and simple workflow that delivers high multiplexing capability with exceptional sensitivity while reducing time-to-results and conserving valuable samples.

The naica system simplifies any digital PCR application by combining high multiplexing assay design compatibility and powerful imaging with the flexibility to use up to six detection channels and proprietary software for analysis. Crystal Miner, the naica system’s proprietary software, offers intuitive visuals for image analysis, enabling thorough exploration of Droplet Crystals for quality control. Crystal Miner measures the concentrations of targeted nucleic acids, enabling automatic identification of positive and negative droplets for all fluorescence channels. The naica system requires minimal technical expertise, as it comes with optimized digital PCR reagents that are ready to use, simple pipetting steps, and chip consumables that are ready for partitioning, amplification, and read-out. Assays can be run with just a few minutes of actual hands-on time, making the naica system highly efficient and user-friendly.

Related Links:
Stilla Technologies 


New
Gold Member
Collection and Transport System
PurSafe Plus®
Collection and Transport System
PurSafe Plus®
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.